NCT00095862 2018-02-05
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
National Cancer Institute (NCI)
Phase 1/2 Terminated
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)